Acute pancreatitis caused by meglumine antimoniate given for the treatment of visceral leishmaniasis.
Lambertucci
José Roberto
JR
Serviço de Doenças Infecciosas e Parasitárias, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brasil.
França
Bruno Mourão
BM
Queiroz
Elisa de Melo
Ede M
D000208:Acute Disease; D000328:Adult; D000981:Antiprotozoal Agents / Q000009:adverse effects*; D006801:Humans; D007898:Leishmaniasis, Visceral / Q000188:drug therapy; D008297:Male; D008536:Meglumine / Q000009:adverse effects*; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds / Q000009:adverse effects*; D010195:Pancreatitis / Q000139:chemically induced*
D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate